Difference between revisions of "Ewing sarcoma"

From Libre Pathology
Jump to navigation Jump to search
(wikify)
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{ Infobox diagnosis
| Name      = {{PAGENAME}}
| Image      = Ewing sarcoma - PAS - high mag.jpg
| Width      =
| Caption    = Ewing sarcoma. [[PAS stain]].
| Micro      = [[small round cell tumour]], clear cytoplasm
| Subtypes  =
| LMDDx      = [[Ewing-like tumours]] (e.g. [[CIC-DUX sarcoma]]), [[small round cell tumours]] ([[lymphoma]], [[small cell osteosarcoma]], others)
| Stains    = [[PAS stain]] +ve, [[PASD stain]] -ve
| IHC        = [[CD99]] +ve, FLI-1 +ve, CD45 -ve
| EM        =
| Molecular  = EWS [[Chromosomal translocations|translocation]], EWS/FLI-1 fusion gene in 90% of cases
| IF        =
| Gross      =
| Grossing  =
| Site      = [[bone]], rarely other sites
| Assdx      =
| Syndromes  =
| Clinicalhx = usually <20 years old
| Signs      =
| Symptoms  =
| Prevalence = uncommon
| Bloodwork  =
| Rads      =
| Endoscopy  =
| Prognosis  =
| Other      =
| ClinDDx    =
}}
'''Ewing sarcoma''', also known as '''EWS/pPNET''', is an uncommon bone tumour.
'''Ewing sarcoma''', also known as '''EWS/pPNET''', is an uncommon bone tumour.


Line 10: Line 39:
*Usually younger than 20 years.
*Usually younger than 20 years.
*Second most common malignant bone tumour in children.
*Second most common malignant bone tumour in children.
**Most common malignant bone tumour = osteosarcoma (AKA osteogenic sarcoma).
**Most common malignant bone tumour = [[osteosarcoma]] ([[AKA]] ''osteogenic sarcoma'').


Poor prognostic factors:<ref>PST. 14 February 2011.</ref>
Poor prognostic factors:<ref>PST. 14 February 2011.</ref>
Line 40: Line 69:
*It is a [[small round cell tumour]].
*It is a [[small round cell tumour]].
*[[Rhabdomyosarcoma]] occasionally has cytoplasmic clearing (due to glycogen).<ref name=PST14feb11>PST. 14 February 2011.</ref>
*[[Rhabdomyosarcoma]] occasionally has cytoplasmic clearing (due to glycogen).<ref name=PST14feb11>PST. 14 February 2011.</ref>
DDx:
*[[Ewing-like tumours]] (e.g. [[CIC-DUX sarcoma]]).
*Large cell [[lymphoma]].
*Other [[small round cell tumours]] (e.g. small cell [[osteosarcoma]]).


====Images====
====Images====
Line 62: Line 96:
*CD45 -ve.  
*CD45 -ve.  
**Done to r/o [[lymphoma]].
**Done to r/o [[lymphoma]].
*+/-Neural markers (NSE, synaptophysin, CD57 (??? CD56 ???), S100).
*+/-Neural markers (NSE, synaptophysin, CD57 (??? CD56 ???), S-100).
*+/-Cytokeratins.
*+/-Cytokeratins.
*Caveolin-1 +ve in ~ 85% of EWS.<ref>PST. 14 February 2011.</ref>
*Caveolin-1 +ve in ~ 85% of EWS.<ref>PST. 14 February 2011.</ref>
Line 68: Line 102:


Notes:<ref>PST. 22 February 2010.</ref>
Notes:<ref>PST. 22 February 2010.</ref>
*CD99 +ve  
*[[CD99]] +ve  
**Plasma membrane staining tumours:
**Plasma membrane staining tumours:
***[[Lymphoblastic lymphoma]]/leukemia.
***[[Lymphoblastic lymphoma]]/leukemia.

Latest revision as of 12:37, 15 October 2015

Ewing sarcoma
Diagnosis in short

Ewing sarcoma. PAS stain.
LM small round cell tumour, clear cytoplasm
LM DDx Ewing-like tumours (e.g. CIC-DUX sarcoma), small round cell tumours (lymphoma, small cell osteosarcoma, others)
Stains PAS stain +ve, PASD stain -ve
IHC CD99 +ve, FLI-1 +ve, CD45 -ve
Molecular EWS translocation, EWS/FLI-1 fusion gene in 90% of cases
Site bone, rarely other sites
Clinical history usually <20 years old
Prevalence uncommon

Ewing sarcoma, also known as EWS/pPNET, is an uncommon bone tumour.

Confusingly, it is known as EWS/PNET. EWS is Ewing sarcoma. pPNET is peripheral primitive neuroectodermal tumour. EWS and pPNET were once thought to be different tumours.

Peripheral primitive neuroectodermal tumour should not be confused with primitive neuroectodermal tumour, commonly abbreviated PNET, a (supertentorial) brain tumour with similarities to medulloblastoma.

General

Clinical:

  • Painful.
  • Usually younger than 20 years.
  • Second most common malignant bone tumour in children.

Poor prognostic factors:[1]

  • Age (18 years-old+).
  • Pelvis (extremity = good).
  • >8 cm.
  • Metastases.
  • EWS-FL1 fusion type 2.
  • >90% necrosis.

Etiology:

  • Unknown origin; hypothesis: Ewing sarcoma arises from mesenchymal stem cell.[2]

Radiology

Features:[3]

  • Long bones, diaphyses.
  • Destructive.
  • "Onion-skin" periosteal reaction.

Microscopic

Features:[4]

  • Scant clear cytoplasm (contain glycogen -- PAS +ve, PAS-D -ve) - key feature.
  • Round small nucleus.
    • Usu. lack nucleoli.
    • Usu. minimal-moderate size variation.
  • Mitoses (common).

Notes:

DDx:

Images

  • ES - intermed. mag.

  • ES - high mag.

  • ES - very high mag.

  • ES - PAS - intermed. mag.

  • ES - PAS - high mag.

  • ES - PAS - very high mag.

www:

IHC

Features:[6]

  • CD99 +ve -- 1. diffuse, 2. plasma membrane staining; both required -- most specific.
  • FLI-1 +ve.[7]
  • CD45 -ve.
  • +/-Neural markers (NSE, synaptophysin, CD57 (??? CD56 ???), S-100).
  • +/-Cytokeratins.
  • Caveolin-1 +ve in ~ 85% of EWS.[8]
  • WT-1 -ve.[9]

Notes:[10]

Molecular diagnostics

Common features:

  • EWS/FLI-1 fusion gene formation due to translocation: t(11;22)(q24;q12).[11][12]
    • Often detected by RT-PCR (with EWS 5' and FLI-1 3' primers).
    • Type 1 = EWS exon 7 + FLI-1 exon 6; good prognosis.
    • Type 2 = others; poor prognosis.

Notes:

  • The t(11;22)(q24;q12) is seen in ~90% of EWS/PNET... but also in:
  • Several other EWS translocations exist.[13]
    • ERG,[14] ETV1, E1AF and FEV.
  • Lack of molecular findings does not exclude Ewing sarcoma.
  • Testing:
    • A break apart probe for EWS is a common way to look for pathologic change, as it covers almost all variants.

Electron microscopy

  • Primitive cell junctions.
  • Clear zone (glycogen lakes).

See also

References

  1. ↑ PST. 14 February 2011.
  2. ↑ Lin PP, Wang Y, Lozano G (2011). "Mesenchymal Stem Cells and the Origin of Ewing's Sarcoma". Sarcoma 2011. doi:10.1155/2011/276463. PMC 2952797. PMID 20953407. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952797/.
  3. ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 650. ISBN 978-0781765275.
  4. ↑ PST. 22 February 2010.
  5. ↑ PST. 14 February 2011.
  6. ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 651. ISBN 978-0781765275.
  7. ↑ 7.0 7.1 Rossi S, Orvieto E, Furlanetto A, Laurino L, Ninfo V, Dei Tos AP (May 2004). "Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody". Mod. Pathol. 17 (5): 547–52. doi:10.1038/modpathol.3800065. PMID 15001993. http://www.nature.com/modpathol/journal/v17/n5/full/3800065a.html.
  8. ↑ PST. 14 February 2011.
  9. ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 286. ISBN 978-0781765275.
  10. ↑ PST. 22 February 2010.
  11. ↑ URL: http://atlasgeneticsoncology.org/Tumors/Ewing5010.html. Accessed on: 23 February 2010.
  12. ↑ Turc-Carel C, Aurias A, Mugneret F, et al. (June 1988). "Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12)". Cancer Genet. Cytogenet. 32 (2): 229–38. PMID 3163261.
  13. ↑ URL: http://www.cancerindex.org/geneweb/EWSR1.htm. Accessed on: 20 November 2011.
  14. ↑ Online 'Mendelian Inheritance in Man' (OMIM) 165080
Retrieved from "https://librepathology.org/w/index.php?title=Ewing_sarcoma&oldid=40589"